Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Decision and Details
Board of DirectorsDelisting of our shares
Decision25 June 2026
Implementation17 July 2026 (scheduled delisting date)
Going forwardThe shares will be delisted as of 17 July 2026.
Reason
The Company fell under the Tokyo Stock Exchange's delisting criteria because it approved a demand for the sale of shares, etc. relating to the Company's common shares and these new share acquisition rights by OMRON HEALTHCARE Co., Ltd., the Special Controlling Shareholder.
| Item | Details |
|---|---|
| Matter Covered | Delisting of our shares |
| Decision-Making Body | Board of Directors |
| Decision Date | 25 June 2026 |
| Implementation Date | 17 July 2026 (scheduled delisting date) |
| Reason | The Company fell under the Tokyo Stock Exchange's delisting criteria because it approved a demand for the sale of shares, etc. relating to the Company's common shares and these new share acquisition rights by OMRON HEALTHCARE Co., Ltd., the Special Controlling Shareholder. |
| Governing Rule | The delisting criteria prescribed in the Securities Listing Regulations of Tokyo Stock Exchange, Inc. |
| Related previous disclosures | Announcement published on 25 June 2026 entitled "Notice Regarding the Decision by OMRON HEALTHCARE Co., Ltd. to Make a Demand for the Sale of Shares, etc. Relating to the Company's Share Certificates, etc., Approval of the Demand for the Sale of Shares, etc., and the Delisting of Our Shares" |
| Future plans | The shares will be delisted as of 17 July 2026. |
Items this document does not state (4)
Period CoveredAmountQuantity / scaleImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The demand for the sale of shares, etc. by OMRON HEALTHCARE Co., Ltd. was approved at the Board of Directors meeting held on 25 June 2026, causing the Company to fall under the Tokyo Stock Exchange's delisting criteria.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.